Chemotherapy-induced nausea and vomiting (CINV) is a major concern for patients which requires prevention. Effective antiemetic regimens can significantly reduce the incidence of both acute and delayed CINV. Adequate prevention requires regimens tailored to the type of chemotherapy a patient will be receiving and are guided by national consensus guidelines.
|Number of pages
|Journal of Managed Care Medicine
|Published - Jul 26 2013
ASJC Scopus subject areas
- Health Policy